期刊
EXPERT REVIEW OF VACCINES
卷 13, 期 3, 页码 365-376出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14760584.2014.877846
关键词
gastroenteritis; rotavirus; rotavirus disease; rotavirus vaccines; vaccines
类别
Prior to the introduction of rotavirus vaccines in 2006, rotavirus was the leading cause of severe gastroenteritis among US children <5 years of age. In the first 7 years of vaccine use, both recommended rotavirus vaccines (RotaTeq [RV5] and Rotarix [RV1]) have been shown to be highly effective in preventing outcomes of severe disease in US children in a variety of settings. In addition, substantial decreases in severe diarrheal disease in US children, exceeding the level expected based on vaccine coverage, as well as the extension of benefits to older age groups ineligible for vaccination have demonstrated both the direct and indirect impacts of vaccination in the USA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据